Prevalence of Type 2 Diabetes Mellitus in Ethiopian Community in Israel: an Update

This study is ongoing, but not recruiting participants.

First Received: November 12, 2006 No Changes Posted

Sponsored by:	HaEmek Medical Center, Israel
Information provided by:	HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier:	NCT00399347

Purpose

The prevalence and incidence of diabetes has been reported to vary among populations.Immigrants groups as that have undergone significant life-style changes tend to develop diabetes within a short time. The aim of the study is to assess the prevalence of diabetes mellitus in Ethiopian population

15-20 years after immigration in Israel.

Condition
Diabetes Mellitus

MedlinePlus related topics: Diabetes

U.S. FDA Resources

Study Type:	Observational
Study Design:	Screening, Cross-Sectional, Defined Population, Retrospective Study
Official Title:	Prevalence of Diabetes Mellitus in Ethiopian Community in Israel: an Update

Further study details as provided by HaEmek Medical Center, Israel:

Estimated Enrollment:	500
Study Start Date:	January 2005
Estimated Study Completion Date:	December 2005

Detailed Description:

The study will be conducted in three primary care clinics of the Jezreel Valley (Omer, Givat Hamore and Afula Illit). The computerized medical charts of 500 Ethiopian adults will be reviewed. The following information will be obtained: age, date of arrival in Israel, known history of diabetes, hyperlipidemia, hypertension or other disease, drug therapy, body weight, blood pressure. Following laboratory data will be retrieved: blood glucose, HbA1c, lipid levels , creatinine and uric acid. The criteria used for the definition of diabetes will be based on the criteria proposed by the American Diabetes Association .

Eligibility

Ages Eligible for Study:	33 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Male and female Ethiopians Jews who immigrate in Israel in 1991 and were 18 years old or more at immigration.

Exclusion Criteria:

Type 1 diabetes Mellitus

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00399347

Locations

Israel
Primary care clinics
Afula, Israel

Sponsors and Collaborators

HaEmek Medical Center, Israel

Investigators

Principal Investigator:

Avraham Ishay MD

HaEmek Medical Center, Afula, Israel

More Information

No publications provided

Study ID Numbers:	4940706
Study First Received:	November 12, 2006
Last Updated:	November 12, 2006
ClinicalTrials.gov Identifier:	NCT00399347 History of Changes
Health Authority:	Israel: Ethics Commission

Keywords provided by HaEmek Medical Center, Israel:

Diabetes Mellitus, prevalence , Ethiopians Jews, Israel

Study placed in the following topic categories:

Metabolic Diseases
Diabetes Mellitus, Type 2
Diabetes Mellitus
Endocrine System Diseases

Endocrinopathy
Glucose Metabolism Disorders
Metabolic Disorder

Additional relevant MeSH terms:

Metabolic Diseases
Diabetes Mellitus, Type 2
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders

ClinicalTrials.gov processed this record on May 07, 2009